B-cell non-Hodgkin Lymphoma - Globe Thesis

Keyword [B-cell non-Hodgkin Lymphoma] Result: 1 - 18 \| Page: 1 of 1
1.	Researching Pathology Classification And Prognosis Of B-cell Non-Hodgkin Lymphoma Using ProteinChip Technology
2.	Expression Of Syndecan-1 And E-Cadherin In Human B-Cell Non-Hodgkin Lymphoma And Clinical Significance
3.	Systematic Review Of Maintenance Rituximab Therapy In B Cell Non-Hodgkin Lymphoma
4.	Study On Cell Growth Control Of B-cell Non-Hodgkin Lymphoma By B Lymphocyte Stimulator
5.	Expression And Significance Of XIAP、Survivin、Bcl-2、Caspase-3and In PCNA In B Cell Non-Hodgkin Lymphoma
6.	Plasma DNA Methylation Of P16and Shpl In Patients With B Cell Non-Hodgkin Lymphoma
7.	Combination Of Rituximab And NK Cells For The Treatment Of Indolent B-cell Non-Hodgkin Lymphoma
8.	Molecular Characteristics Of IGVH And Antigen Selection In EBV Infected B-NHL Cell Lines
9.	The Expression And Significance Of IL-17 And IL-23 In Peripheral Blood Of Patients With B-Cell Non-Hodgkin Lymphoma
10.	The Expression And Proliferation Effect Of IgD In B Cell Non-Hodgkin Lymphoma And Partial Mechanism
11.	The Investigation On Gambogic Acid-induced SRC-3 Inhibition And Histone Deacetylation In The Treatments Of B-cell Non-Hodgkin Lymphoma
12.	A System Review Of Rituximab As Maintenance Therapy For Aggressive B Cell Non-Hodgkin Lymphoma
13.	The Efficacy Contrast Of Lamivudine And Enticavir In Preventing Rituximab-associated Hepatitis B Virus Reactivation In Patients With B-cell Non-hodgkin Lymphoma Complicated Hbv Infection During Chemotherapy
14.	The Clinical Features And Prognosis Of Children Mature B-cell Non-Hodgkin Lymphoma(B-NHL):30 Cases Reported
15.	Clinical Characteristics And Prognosis Of B-cell Non-Hodgkin Lymphoma With Abnormal Leukocyte Count
16.	Clinical Prognostic Analysis Of 49 Patients With Primary Intestinal B-cell Non-hodgkin Lymphoma
17.	Basic And Clinical Study On CD19-CAR-T Cells For B Cell Non-hodgkin Lymphoma
18.	Clinical Study Of Targeting CD19 Fourth-generation Chimeric Antigen Receptor T Cells In Treating Relapsed Or Refractory B Cell Non-hodgkin Lymphoma
<<First <Prev Next> Last>> Jump to